The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia
Open accessAbstract
The pathogenesis of septic shock occurring after Pseudomonas aeruginosa pneumonia was studied in a rabbit model. The airspace instillation of the cytotoxic P. aeruginosa strain PA103 into the rabbit caused a consistent alveolar epithelial injury, progressive bacteremia, and septic shock. The lung instillation of a noncytotoxic, isogenic mutant strain (PA103DeltaUT), which is defective for production of type III secreted toxins, did not cause either systemic inflammatory response or septic shock, despite a potent inflammatory response in the lung. The intravenous injection of PA103 did not cause shock or an increase in TNF-alpha, despite the fact that the animals were bacteremic. The systemic administration of either anti-TNF-alpha serum or recombinant human IL-10 improved both septic shock and bacteremia in the animals that were instilled with PA103. Radiolabeled TNF-alpha instilled in the lung significantly leaked into the circulation only in the presence of alveolar epithelial injury. We conclude that injury to the alveolar epithelium allows the release of proinflammatory mediators into the circulation that are primarily responsible for septic shock. Our results demonstrate the importance of compartmentalization of inflammatory mediators in the lung, and the crucial role of bacterial cytotoxins in causing alveolar epithelial damage in the pathogenesis of acute septic shock in P. aeruginosa pneumonia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An experimental study of rabbits with severe Pseudomonas pneumonia and systemic sepsis provided definitive evidence that TNF instilled into the lungs could pass into the systemic circulation, providing direct communication between the lungs and the bloodstream (80).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathophysiology of Tumor Necrosis Factors
VASSALLI, P. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.002211 · Cited by 1,874
Espevik, T., & Nissen-Meyer, J. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90322-4 · Cited by 1,256
Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., & Ognibene, F. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-227 · Cited by 1,188
Fagon, J.-Y., Chastre, J. E., Hance, A. J., Montravers, P., Novara, A., & Gibert, C. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90060-3 · Cited by 1,175
Incidence, Risk, and Prognosis Factors of Nosocomial Pneumonia in Mechanically Ventilated Patients
Torres, A., Aznar, R., Gatell, J. M., Jiménez, P., González, J., Ferrer, A., Celis, R., & Rodriguez‐Roisin, R. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.3.523 · Cited by 913
TUMOR NECROSIS, CACHEXIA, SHOCK, AND INFLAMMATION: A COMMON MEDIATOR
Beutler, B., & Cerami, A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002445 · Cited by 805
Reddel, R. R., Ke, Y., Gerwin, B. I., McMenamin, M. G., Lechner, J. F., Su, R., Brash, D. E., Park, J. B., Rhim, J. S., & Harris, C. C. (1988) · PubMed · Cited by 783
Clinical predictors of the adult respiratory distress syndrome
Pepe, P. E., Potkin, R. T., Reus, D. H., Hudson, L. D., & Carrico, C. J. (1982) · The American Journal of Surgery · doi:10.1016/0002-9610(82)90612-2 · Cited by 687
Inflammatory Cytokines in Patients With Persistence of the Acute Respiratory Distress Syndrome
Goodman, R. B., Strieter, R. M., Martin, D. P., Steinberg, K. P., MILBERG, J. A., Maunder, R. J., Kunkel, S. L., Walz, A., Hudson, L. D., & Martin, T. R. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810593 · Cited by 528
Self-citationExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
Finck‐Barbançon, V., Goranson, J., Zhu, L., Sawa, T., Wiener‐Kronish, J. P., Fleiszig, S. M. J., Wu, C. C., Mende‐Mueller, L., & Frank, D. W. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4891851.x · Cited by 518
Self-citation
Flagged first, then by citations
1 of the 36 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- Rouby, 1996, Semin Respir Infect, 11, 54
- Craven, 1996, Semin Respir Infect, 11, 32
- Sawa, 1998, Infect Immun, 65, 579
- Kudoh, 1994, Am J Physiol, 267, L551
- Reddel, 1988, Cancer Res, 48, 1904
- Wiener-Kronish, 1991, J Clin Invest, 88, 864, 10.1172/JCI115388 · DOI
Cited by
Sorted by citations
The Acute Respiratory Distress Syndrome
Ware, L. B., & Matthay, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421806 · Cited by 4,666
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
Self-citationBouchama, A., & Knochel, J. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011089 · Cited by 1,898
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 971
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 827
The cytokine storm of severe influenza and development of immunomodulatory therapy
Liu, Q., Zhou, Y., & Yang, Z. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.74 · Cited by 725
Lung Epithelial Fluid Transport and the Resolution of Pulmonary Edema
Matthay, M. A., Folkesson, H. G., & Clérici, C. (2002) · Physiological Reviews · doi:10.1152/physrev.00003.2002 · Cited by 670
Matthay, M. A., Zimmerman, G. A., Esmon, C. T., Bhattacharya, J., Coller, B. S., Doerschuk, C. M., Floros, J., Gimbrone, M. A., Hoffman, E., Hubmayr, R. D., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-966ws · Cited by 503
Acute Lower Respiratory Tract Infection
Mizgerd, J. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmra074111 · Cited by 455
Feltman, H., Schulert, G. S., Khan, S., Jain, M., Peterson, L. R., & Hauser, A. R. (2001) · Microbiology · doi:10.1099/00221287-147-10-2659 · Cited by 446
Hauser, A. R., Cobb, E. M., Bodí, M. A., Mariscal, D., Vallés, J., Engel, J. N., & Rello, J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00005 · Cited by 399
The mechanism of action of the Pseudomonas aeruginosa‐encoded type III cytotoxin, ExoU
Satō, H., Frank, D. W., Hillard, C. J., Feix, J. B., Pankhaniya, R. R., Moriyama, K., Finck‐Barbançon, V., Buchaklian, A., Lei, M., Long, R. M., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg290 · Cited by 390
Self-citationTargeting mechanisms of Pseudomonas aeruginosa pathogenesis
Kipnis, É., Sawa, T., & Wiener-Kronish, J. P. (2006) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2005.10.007 · Cited by 356
Self-citationRelative Contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to Virulence in the Lung
Shaver, C. M., & Hauser, A. R. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.6969-6977.2004 · Cited by 350
The Accessory Genome of Pseudomonas aeruginosa
Kung, V. L., Ozer, E. A., & Hauser, A. R. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00027-10 · Cited by 340
Regulation and Repair of the Alveolar-Capillary Barrier in Acute Lung Injury
Bhattacharya, J., & Matthay, M. A. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183756 · Cited by 348
Chemani, C., Imberty, A., de Bentzmann, S., Pierre, M., Wimmerová, M., Guery, B. P., & Faure, K. (2009) · Infection and Immunity · doi:10.1128/iai.01204-08 · Cited by 329
Pseudomonas aeruginosa activates caspase 1 through Ipaf
Miao, E. A., Ernst, R. K., Dors, M., Mao, D. P., & Aderem, A. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712183105 · Cited by 299
ExoU is a potent intracellular phospholipase
Satō, H., & Frank, D. W. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04194.x · Cited by 287
Self-citationTranscriptional regulation of the Pseudomonas aeruginosa type III secretion system
Yahr, T. L., & Wolfgang, M. C. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05412.x · Cited by 240
Local Inflammatory Responses following Bronchial Endotoxin Instillation in Humans
O’Grady, N. P., Preas, H. L., Pugin, J., Fiuza, C., Tropea, M., Reda, D., BANKS, S. M., & Suffredini, A. F. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2009111 · Cited by 214
Severe Sepsis — A New Treatment with Both Anticoagulant and Antiinflammatory Properties
Matthay, M. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441009 · Cited by 209
Alverdy, J., Holbrook, C., Rocha, F., Seiden, L., Licheng, R., Wu, Musch, M., Chang, E., Ohman, D., & Suh, S. (2000) · Annals of Surgery · doi:10.1097/00000658-200010000-00003 · Cited by 207
Alveolar Epithelium: Role in Lung Fluid Balance and Acute Lung Injury
Matthay, M. A., Robriquet, L., & Fang, X. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200501-009ac · Cited by 203
Galani, V., Tatsaki, E., Bai, M. C., Kitsoulis, P., Lekka, M. E., Νάκος, Γ., & Kanavaros, P. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2009.12.002 · Cited by 203
Alverdy, J. C., Laughlin, R. S., & Wu, L. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000045576.55937.67 · Cited by 200
Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*
Veesenmeyer, J. L., Hauser, A. R., Lisboa, T. C., & Rello, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819ff137 · Cited by 202
Vance, R. E., Rietsch, A., & Mekalanos, J. J. (2005) · Infection and Immunity · doi:10.1128/iai.73.3.1706-1713.2005 · Cited by 193
Finnan, S., Morrissey, J. P., O’Gara, F., & Boyd, E. F. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5783-5792.2004 · Cited by 192
Allewelt, M., Coleman, F. T., Grout, M., Priebe, G. P., & Pier, G. B. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.3998-4004.2000 · Cited by 190
Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infections
Strateva, T., & Mitov, I. (2011) · Annals of Microbiology · doi:10.1007/s13213-011-0273-y · Cited by 187
DuBois, R. M., Six, D. A., Dennis, E. A., & Ghosh, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302472200 · Cited by 194
Ishizaka, A., Matsuda, T., Albertine, K. H., Koh, H., Tasaka, S., Hasegawa, N., Kohno, N., Kotani, T., Morisaki, H., Takeda, J., et al. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00420.2002 · Cited by 174
Self-citationLund‐Palau, H., Turnbull, A. R., Bush, A., Bardin, E., Cameron, L. P., Soren, O., Wierre-Gore, N., Alton, E. W. F. W., Bundy, J. G., Connett, G. J., et al. (2016) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2016.1177460 · Cited by 165
Kuang, Z., Hao, Y., Walling, B. E., Jeffries, J. L., Ohman, D. E., & Lau, G. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027091 · Cited by 150
Streeter, K., & Katouli, M. (2016) · Infection Epidemiology and Medicine · doi:10.18869/modares.iem.2.1.25 · Cited by 167
SEVERE SEPSIS AND SEPTIC SHOCK: The Role of Gram-Negative Bacteremia
Munford, R. S. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100200 · Cited by 150
Sawa, T., Shimizu, M., Moriyama, K., & Wiener-Kronish, J. P. (2014) · Critical Care · doi:10.1186/s13054-014-0668-9 · Cited by 147
Self-citationHubmayr, R. D. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1514-0 · Cited by 147
Alverdy, J. C., & Chang, E. B. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607372 · Cited by 147
Structure and Function of the Type III Secretion System of Pseudomonas aeruginosa
Galle, M., Carpentier, I., & Beyaert, R. (2012) · Current Protein and Peptide Science · doi:10.2174/138920312804871210 · Cited by 141
Smith, R. S., Wolfgang, M. C., & Lory, S. J. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1677-1684.2004 · Cited by 129
Acquisition and Evolution of theexoULocus inPseudomonas aeruginosa
Kulasekara, B. R., Kulasekara, H. D., Wolfgang, M. C., Stevens, L., Frank, D. W., & Lory, S. (2006) · Journal of Bacteriology · doi:10.1128/jb.02000-05 · Cited by 125
Self-citationThe role of lipid rafts in the pathogenesis of bacterial infections
Zaas, D., Duncan, M. J., Wright, J. R., & Abraham, S. N. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.10.003 · Cited by 125
Therapeutic Administration of Anti-PcrV F(ab′)2 in Sepsis Associated with Pseudomonas aeruginosa
Shime, N., Sawa, T., Fujimoto, J., Faure, K., Allmond, L. R., Karaca, T. J., Swanson, B. L., Spack, E. G., & Wiener-Kronish, J. P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5880 · Cited by 123
Self-citationInjury and repair in lung and airways
Shimabukuro, D. W., Sawa, T., & Gropper, M. A. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000081437.06466.b3 · Cited by 122
Self-citationPatatin-like proteins: a new family of lipolytic enzymes present in bacteria?
Banerji, S., & Flieger, A. (2004) · Microbiology · doi:10.1099/mic.0.26957-0 · Cited by 120
Sawa, T. (2014) · Journal of Intensive Care · doi:10.1186/2052-0492-2-10 · Cited by 117
Self-citationDetoxifying endotoxin: time, place and person
Munford, R. S. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x35161 · Cited by 152
Alveolar Epithelial Ion and Fluid Transport
Folkesson, H. G., & Matthay, M. A. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0080sf · Cited by 112
Pseudomonas aeruginosa – Pathogenesis and Pathogenic Mechanisms
Alhazmi, A. (2015) · International Journal of Biology · doi:10.5539/ijb.v7n2p44 · Cited by 111
Koff, J. L., Shao, M. X. G., Kim, S., Ueki, I. F., & Nadel, J. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8693 · Cited by 111
Serious Infections Associated with Anticytokine Therapies in the Rheumatic Diseases
Giles, J. T., & Bathon, J. M. (2004) · Journal of Intensive Care Medicine · doi:10.1177/0885066604267854 · Cited by 110
A novel signaling mechanism between gas and blood compartments of the lung
Kuebler, W. M., Parthasarathi, K., Wang, P. M., & Bhattacharya, J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8604 · Cited by 109
Secreted bacterial phospholipase A2 enzymes: better living through phospholipolysis
Sitkiewicz, I., Stockbauer, K. E., & Musser, J. M. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.12.003 · Cited by 104
Pseudomonas aeruginosa Cytotoxin ExoU Is Injected into Phagocytic Cells during Acute Pneumonia
Diaz, M. H., & Hauser, A. R. (2010) · Infection and Immunity · doi:10.1128/iai.01134-09 · Cited by 104
Pseudomonas aeruginosa Induces Localized Immunosuppression during Pneumonia
Diaz, M. H., Shaver, C. M., King, J. D., Musunuri, S., Kazzaz, J. A., & Hauser, A. R. (2008) · Infection and Immunity · doi:10.1128/iai.00012-08 · Cited by 99
Neutrophil Elastase Mediates Innate Host Protection against Pseudomonas aeruginosa
Hirche, T. O., Benabid, R., Deslée, G., Gangloff, S. C., Achilefu, S. A., Guenounou, M., Lebargy, F., Hancock, R. E. W., & Belaaouaj, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4945 · Cited by 99
Brutinel, E. D., Vakulskas, C. A., Brady, K. M., & Yahr, T. L. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06179.x · Cited by 96
Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX‐2
Sadikot, R. T., Zeng, H., Azim, A. C., Joo, M., Dey, S. K., BREYER, R. M., Peebles, R. S., Blackwell, T. S., & Christman, J. W. (2007) · European Journal of Immunology · doi:10.1002/eji.200636636 · Cited by 96
Marriott, H. M., Hellewell, P. G., Cross, S. S., Ince, P. G., Whyte, M. K. B., & Dockrell, D. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6480 · Cited by 96
Inflammatory response to infectious pulmonary injury
Delclaux, C., & Azoulay, É. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00420203 · Cited by 95
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
Lü, Q., Eggimann, P., Luyt, C. E., Wolff, M., Tamm, M., François, B., Mercier, E., Garbino, J., Laterre, P., Koch, H., et al. (2014) · Critical Care · doi:10.1186/cc13697 · Cited by 91
Ryu, J.-C., Kim, M.-J., Kwon, Y., Oh, J., Yoon, S. S., Shin, S. J., Yoon, J.-H., & Ryu, J.-H. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.73 · Cited by 87
Ajayi, T., Allmond, L. R., Sawa, T., & Wiener-Kronish, J. P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3526-3531.2003 · Cited by 87
Self-citationZiltener, P., Reinheckel, T., & Oxenius, A. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005591 · Cited by 84
Faure, K., Sawa, T., Ajayi, T., Fujimoto, J., Moriyama, K., Shime, N., & Wiener-Kronish, J. P. (2004) · Respiratory Research · doi:10.1186/1465-9921-5-1 · Cited by 85
Self-citationEicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU
Saliba, A. M., Nascimento, D. O., da Silva, M. C. A., de Assis, M. C., Gayer, C. R. M., Raymond, B., Coelho, M. G. P., Marques, E. A., Touqui, L., Albano, R. M., et al. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00635.x · Cited by 85
Septic Shock and Acute Lung Injury in Rabbits with Peritonitis
Matute‐Bello, G., Frevert, C. W., Kajikawa, O., Skerrett, S. J., Goodman, R. B., Park, D. R., & MARTIN, T. R. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.9909034 · Cited by 85
Self-citationSimeonova, P. P., & Erdely, A. (2009) · Inhalation Toxicology · doi:10.1080/08958370902942566 · Cited by 85
Novel Role of the Human Alveolar Epithelium in Regulating Intra-Alveolar Coagulation
Wang, L., Bastarache, J. A., Wickersham, N. E., Fang, X., Matthay, M. A., & Ware, L. B. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0425oc · Cited by 85
Anti-PcrV antibody strategies against virulentPseudomonas aeruginosa
Sawa, T., Ito, E., Nguyen, V. H., & Haight, M. J. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.971641 · Cited by 83
Self-citationFaure, K., Fujimoto, J., Shimabukuro, D. W., Ajayi, T., Shime, N., Moriyama, K., Spack, E. G., Wiener-Kronish, J. P., & Sawa, T. (2003) · Journal of Immune Based Therapies and Vaccines · doi:10.1186/1476-8518-1-2 · Cited by 83
Self-citationCan the Cecal Ligation and Puncture Model Be Repurposed To Better Inform Therapy in Human Sepsis?
Alverdy, J. C., Keskey, R. C., & Thewissen, R. (2020) · Infection and Immunity · doi:10.1128/iai.00942-19 · Cited by 81
Pankhaniya, R. R., Tamura, M., Allmond, L. R., Moriyama, K., Ajayi, T., Wiener-Kronish, J. P., & Sawa, T. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145588.79063.07 · Cited by 81
Self-citationControl of effector export by the Pseudomonas aeruginosa type III secretion proteins PcrG and PcrV
Lee, P., Stopford, C. M., Svenson, A. G., & Rietsch, A. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.07027.x · Cited by 80
Zaas, D., Duncan, M. J., Li, G., Wright, J. R., & Abraham, S. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411702200 · Cited by 79
Analytic Review: The Pathogenetic and Prognostic Value of Biologic Markers in Acute Lung Injury
Levitt, J. E., Gould, M. K., Ware, L. B., & Matthay, M. A. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609332603 · Cited by 78
Priebe, G. P., Dean, C. R., Zaidi, T., Meluleni, G. J., Coleman, F. T., Coutinho-Sledge, Y. S., Noto, M. J., Urban, T. A., Pier, G. B., & Goldberg, J. B. (2004) · Infection and Immunity · doi:10.1128/iai.72.7.4224-4232.2004 · Cited by 79
Identification of Superoxide Dismutase as a Cofactor for the Pseudomonas Type III Toxin, ExoU
Satō, H., Feix, J. B., & Frank, D. W. (2006) · Biochemistry · doi:10.1021/bi060788j · Cited by 78
Self-citationLook, D. C., Stoll, L. L., Romig‐Martin, S. A., Humlicek, A. L., Britigan, B. E., & Denning, G. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.4017 · Cited by 77
Gendrin, C., Contreras‐Martel, C., Bouillot, S., Elsen, S., Lemaire, D., Skoufias, D. A., Huber, P., Attrée, I., & Dessen, A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002637 · Cited by 76
Wu, L., Holbrook, C., Zaborina, O. Y., Ploplys, E., Rocha, F., Pelham, D. J., Chang, E. B., Musch, M. W., & Alverdy, J. C. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000094551.88143.f8 · Cited by 75
Pène, F., Zuber, B., Courtine, E., Rousseau, C., Ouaaz, F., Toubiana, J., Tazi, A., Mira, J. P., & Chiche, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8513 · Cited by 78
Keratinocyte growth factor protects againstPseudomonas aeruginosa-induced lung injury
Viget, N. B., Guery, B. P., Ader, F., Nevière, R., Alfandari, S., Creuzy, C., Roussel‐Delvallez, M., Foucher, C., Mason, C. M., Beaucaire, G., et al. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1199 · Cited by 76
Acute lung injury and acute respiratory distress syndrome in pregnancy
Bandi, V., Munnur, U., & Matthay, M. A. (2004) · Critical Care Clinics · doi:10.1016/j.ccc.2004.05.010 · Cited by 76
Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia*
Berre, R. L., Nguyen, S., Nowak, E., Kipnis, É., Pierre, M., Quenee, L. E., Ader, F., Lancel, S., Courcol, R., Guery, B. P., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e899f · Cited by 75
Lung injury in acute pancreatitis: Mechanisms underlying augmented secondary injury
Elder, A. S. F., Saccone, G. T. P., & Dixon, D. (2012) · Pancreatology · doi:10.1016/j.pan.2011.12.012 · Cited by 73
Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU
Tamura, M., Ajayi, T., Allmond, L. R., Moriyama, K., Wiener-Kronish, J. P., & Sawa, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.050 · Cited by 72
Self-citationVirulence Factors from Pseudomonas aeruginosa Increase Lung Epithelial Permeability
Azghani, A. O., Miller, E. J., & Peterson, B. T. (2000) · Lung · doi:10.1007/s004080000031 · Cited by 72
Huppert, L. A., & Matthay, M. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00371 · Cited by 72
Zhuo, H., Yang, K. Y., Lynch, S. V., Dotson, R. H., Glidden, D. V., Singh, G., Webb, W. R., Elicker, B. M., García, Ó., Brown, R., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318183f3f8 · Cited by 70
Self-citationInflammatory and Fibrinolytic System in Acute Respiratory Distress Syndrome
Gouda, M. M., Shaikh, S. B., & Bhandary, Y. P. (2018) · Lung · doi:10.1007/s00408-018-0150-6 · Cited by 68
Metalloproteases from Pseudomonas aeruginosa Degrade Human RANTES, MCP-1, and ENA-78
Leidal, K. G., Munson, K. L., Johnson, M. C., & Denning, G. M. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003766628151 · Cited by 68
Multiple Domains Are Required for the Toxic Activity of Pseudomonas aeruginosa ExoU
Finck‐Barbançon, V., & Frank, D. W. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.14.4330-4344.2001 · Cited by 68
Self-citationNuclear Factor-κB p50 Limits Inflammation and Prevents Lung Injury during Escherichia coli Pneumonia
Mizgerd, J. P., Lupa, M. M., Kogan, M. S., Warren, H. B., Kobzik, L., & Topulos, G. P. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200303-412oc · Cited by 66
Silva, K. D. C. F. D. A., Calomino, M. A., Deutsch, G., de Castilho, S. R., de Paula, G. R., Esper, L. M. R., & Teixeira, L. A. (2016) · Burns · doi:10.1016/j.burns.2016.07.002 · Cited by 63
Schortgen, F., Bouadma, L., Joly‐Guillou, M., Ricard, J.-D., Dreyfuss, D., & Saumon, G. (2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2147-7 · Cited by 61
Robriquet, L., Collet, F., Tournoys, A., Prangère, T., Nevière, R., Fourrier, F., & Guery, B. P. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-41 · Cited by 62
Terahertz thermal curve analysis for label-free identification of pathogens
Jun, S. W., & Ahn, Y. H. (2022) · Nature Communications · doi:10.1038/s41467-022-31137-2 · Cited by 60
Metadata
- Authors
- Kurahashi, K., Kajikawa, O., Sawa, T., Ohara, M., Gropper, M. A., Frank, D. W., Martin, T. R., & Wiener-Kronish, J. P.
- Affiliations
- University of California, San Francisco (US)
- University of Washington (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Wiener-Kronish, Jeanine P.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 743-750
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408437
- OpenAlex
- W2087967484
- Cited by
- 316
- References
- 36
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 9 · 2021: 8 · 2020: 7 · 2019: 4 · 2018: 7 · 2017: 11 · 2016: 14 · 2015: 14 · 2014: 18 · 2013: 8 · 2012: 16
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL49810, HL-59239, R01HL059239, R01HL049810)
- National Institute of General Medical Sciences (P01GM037696)
- National Institute of Allergy and Infectious Diseases (AI31665)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- septic shock, Pseudomonas aeruginosa pneumonia, type III secretion system, alveolar epithelial injury, TNF-α, IL-10, bacteremia, systemic inflammatory response, rabbit model
- MeSH terms
- Animals, Cell Line, Humans, Male, Pseudomonas aeruginosa, Pseudomonas Infections, Rabbits, Recombinant Proteins, Shock, Septic, Tumor Necrosis Factor-alpha, Interleukin-10, Pneumonia, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review